BUFFALO, N.Y. – Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an ...

Please provide your email address to receive an email when new articles are posted on . Researchers conducted a study of 431 adults with multiple sclerosis. Data showed lesion volume and damage were ...

In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...

Myelocortical multiple sclerosis (MCMS) is a new subtype of multiple sclerosis (MS). It’s the first kind of MS known to cause nerve cell loss without damaging the myelin in your cerebral white matter.

A new study potentially shows how the brains of superagers — people with outstanding cognitive performance despite their age — resist age-related decline. The report, published April 29 in the Journal ...

Please provide your email address to receive an email when new articles are posted on . Higher systolic and diastolic blood pressure for recently postmenopausal women was tied to greater white matter ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

WEST PALM BEACH, FL – The presence of paramagnetic rim lesions (PRLs) on MRI may help in the diagnosis of multiple sclerosis (MS), as well as in predicting more severe disease course, new research ...

Changes in NAWM and NAGM are crucial in MS progression, challenging the traditional lesion-centric model. Subtle alterations in myelin integrity, immune cell function, and neuronal connectivity ...